The New England Journal of Medicine | Research & Review Articles on ...
26 Feb 2026 at 4:47am
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2 Jun 2025 at 2:38pm
Tarlatamab, a bispecific delta-like ligand 3?directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer ...
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
28 Feb 2025 at 11:53pm
Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, but its efficacy and saf...
Phase 3 Trial of Semaglutide in Metabolic Dysfunction?Associated ...
29 Apr 2025 at 11:54pm
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction?associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...
The New England Journal of Medicine
13 Jan 2026 at 2:33am
The New England Journal of Medicine
A Crossover Trial of Hospital-Wide Lactated Ringer?s Solution versus ...
11 Jun 2025 at 11:53pm
Whether lactated Ringer?s solution is clinically superior to normal saline for routine intravenous administration of fluids is uncertain. In an open-label, two-period, two-sequence, cross ...
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
31 May 2025 at 11:59pm
In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program ...
Remibrutinib in Chronic Spontaneous Urticaria | New England Journal of ...
6 Mar 2025 at 3:44am
Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. Remibrutinib, an oral, highly sel...
Lorundrostat Efficacy and Safety in Patients with Uncontrolled ...
22 Apr 2025 at 11:55pm
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited.
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
3 Feb 2026 at 11:58pm
Enlicitide decanoate, an oral proprotein convertase subtilisin?kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer ...
WHAT IS THIS? This is an unscreened compilation of results from several search engines. The sites listed are not necessarily recommended by Surfnetkids.com.
26 Feb 2026 at 4:47am
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2 Jun 2025 at 2:38pm
Tarlatamab, a bispecific delta-like ligand 3?directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer ...
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
28 Feb 2025 at 11:53pm
Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, but its efficacy and saf...
Phase 3 Trial of Semaglutide in Metabolic Dysfunction?Associated ...
29 Apr 2025 at 11:54pm
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction?associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...
The New England Journal of Medicine
13 Jan 2026 at 2:33am
The New England Journal of Medicine
A Crossover Trial of Hospital-Wide Lactated Ringer?s Solution versus ...
11 Jun 2025 at 11:53pm
Whether lactated Ringer?s solution is clinically superior to normal saline for routine intravenous administration of fluids is uncertain. In an open-label, two-period, two-sequence, cross ...
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
31 May 2025 at 11:59pm
In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured exercise program ...
Remibrutinib in Chronic Spontaneous Urticaria | New England Journal of ...
6 Mar 2025 at 3:44am
Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. Remibrutinib, an oral, highly sel...
Lorundrostat Efficacy and Safety in Patients with Uncontrolled ...
22 Apr 2025 at 11:55pm
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited.
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
3 Feb 2026 at 11:58pm
Enlicitide decanoate, an oral proprotein convertase subtilisin?kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer ...
WHAT IS THIS? This is an unscreened compilation of results from several search engines. The sites listed are not necessarily recommended by Surfnetkids.com.